Immtech Pharmaceuticals

Immtech "has an exclusive worldwide license to develop and commercialize patented compounds derived from a proprietary medicinal platform."

Directors
Accessed March 2008:


 * Eric L. Sorkin - Chairman and Chief Executive Officer
 * Cecilia Chan - Executive Director and Board Member
 * David Fleet - Principal, David Fleet Pharmaceutical Industry Consultancy Services, Non-Executive Director, OnMedica Group Ltd. ,Director, IatRx Pharma Ltd.
 * Judy Lau - Chairperson, Convergent Business Group, Hong Kong, PRC
 * Levi Hong Kaye Lee - Queen Mary Hospital, Hong Kong, PRC
 * Donald F. Sinex - Board Director, Devonwood, Inc.

Advisors
 * Dorothy S. Zinberg - Center for Science and International Affairs Kennedy School of Government, Harvard University

Contact

 * Web: http://www.immtechpharma.com

Related Sourcewatch articles

 * Wesley Kanne Clark - former strategic advisor